-
Mashup Score: 17Young oncologists’ perspective on the role and future of the clinician-scientist in oncology - 9 month(s) ago
© 2023 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 14CTOS > Meeting > 2023 Annual Meeting - 1 year(s) ago
The Connective Tissue Oncology Society is a non-profit professional medical organization whose members are a multidisciplinary group of specialized physicians, medical professionals, and scientists from around the world to connect, and share their knowledge, experiences, and research for the advancement of treatment of sarcomas. If you are interested in becoming a member and serving on a…
Source: www.ctos.orgCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 5Home Page: Surgical Oncology Clinics - 2 year(s) ago
October 2022 Oncology Imaging: Updates and Advancements Edited by Natalie S. Lui Imaging is at the core of surgical oncology. Longstanding techniques, such as computed tomography and MRI, as well as nuclear medicine methods, such as PET, have been studied and refined over the years. They form the basis of preoperative staging and complex surgical planning. For a long time, surgeons relied on…
Source: www.surgonc.theclinics.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6Home Page: Surgical Clinics - 2 year(s) ago
August 2022 A Surgeon’s Guide to Sarcomas and Other Soft Tissue Tumors Edited by John M. Kane Surgeons are frequently referred patients for the evaluation of a soft tissue mass. Given that “common things occur commonly,” the majority will be benign entities such as a lipoma, epidermal inclusion cyst, hematoma, abscess, ganglion cyst, and such. Surgical excision is often the definitive treatment….
Source: www.surgical.theclinics.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 6
Antitumor T cell responses are the primary mediators of cancer immunotherapy. However, many other components of the immune system are needed for efficient T cell responses to be generated. Here, we developed a combinatorial approach where a Toll-like receptor 9 agonist (CpG) and Fc-fused IL-12 prote …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Black Medicare beneficiaries who underwent elective cancer surgery had higher rates of mortality than their white counterparts, irrespective of neighborhood deprivation or dual eligibility status, according to study results.The findings, presented at Society of Surgical Oncology International 2022 Conference on Surgical Cancer Care, also showed a more pronounced effect of race among those with
Source: www.healio.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 11Immune-checkpoint inhibitors: long-term implications of toxicity - Nature Reviews Clinical Oncology - 2 year(s) ago
Immune-checkpoint inhibitors (ICIs) have dramatically improved the outcomes of patients with advanced-stage solid tumours, including the potential for long-term remission in a subset. However, long-term follow-up data reveal a risk of chronic toxicities from these agents, which can have important quality-of-life implications. In this Review, the authors describe the current level of evidence of…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
RT @AndresC27622123: Young oncologists’ perspective on the role and future of the clinician... https://t.co/709U7gsF77